Adverum Biotechnologies, Inc. (ADVM)
Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)
4.360
+0.100 (2.35%)
Inactive · Last trade price on Dec 8, 2025
Adverum Biotechnologies Employees
Adverum Biotechnologies had 155 employees as of December 31, 2024. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
n/a
Profits / Employee
-$1,192,213
Market Cap
96.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155 | 34 | 28.10% |
| Dec 31, 2023 | 121 | -2 | -1.63% |
| Dec 31, 2022 | 123 | -65 | -34.57% |
| Dec 31, 2021 | 188 | 21 | 12.57% |
| Dec 31, 2020 | 167 | 53 | 46.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
ADVM News
- 9 days ago - Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - PRNewsWire
- 17 days ago - Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - GlobeNewsWire
- 7 weeks ago - Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM - Business Wire
- 7 weeks ago - Eli Lilly to buy gene therapy developer Adverum in about $262 million deal - Reuters
- 7 weeks ago - Lilly to Acquire Adverum Biotechnologies - PRNewsWire
- 3 months ago - Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire